Autologous Haematopoietic Stem Cell Transplant refers to a treatment scheme where a patient’s haematopoietic (or blood) stem cells are isolated from their bone marrow, before their immune system is removed either by chemotherapy or whole body irradiation. The patient’s own haematopoietic stem cells are then reintroduced back into their body to rebuild the immune system.
Increasing awareness, participation, funding and streamlining communication for MS trials